Trump Pauses Iran Strikes, Wall Street Rallies
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy STZ?
Source: seekingalpha
- Market Rally: Wall Street closed higher on Wednesday, with the Nasdaq Composite up 2.8%, S&P 500 rising 2.5%, and Dow climbing 2.8%, following President Trump's agreement to pause planned strikes on Iran, indicating a positive market response to reduced geopolitical risks.
- ImmuCell Strong Performance: ImmuCell's stock surged 5.02% to $6.70 in after-hours trading after reporting first-quarter sales of $10.4 million, a 28.4% year-over-year increase, primarily driven by robust domestic sales, highlighting strong demand for its Tri-Shield product line.
- Costco Sales Growth: Despite reporting net sales of $28.41 billion for March, an 11.3% increase year-over-year, Costco's stock fell 0.52% to $1,024.92 in postmarket trading, reflecting market caution regarding future growth, even with e-commerce sales jumping 23.3%.
- Constellation Brands Soft Guidance: Constellation Brands faced pressure in after-hours trading after reporting fiscal fourth-quarter earnings of $1.90 per share, beating estimates, but issuing a fiscal 2027 earnings guidance below Wall Street expectations, indicating uncertainty in future market demand.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy STZ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on STZ
Wall Street analysts forecast STZ stock price to rise
15 Analyst Rating
7 Buy
7 Hold
1 Sell
Moderate Buy
Current: 153.830
Low
135.00
Averages
163.00
High
209.00
Current: 153.830
Low
135.00
Averages
163.00
High
209.00
About STZ
Constellation Brands, Inc. is a producer and marketer of beer, wine, and spirits with operations in the United States, Mexico, New Zealand, and Italy with brands, such as Corona Extra, Modelo Especial, Robert Mondavi Winery, Kim Crawford, The Prisoner Wine Company, High West, Casa Noble, and Mi CAMPO. Its segments include Beer, Wine and Spirits, and Corporate Operations and Other. In the Beer segment, its portfolio consists of high-end imported beer brands and ABAs. It has a perpetual brand license to produce its Mexican beer portfolio and to import, market, and sell such a portfolio in the United States. In the Wine and Spirits segment, it sells a portfolio that includes higher-end wine brands complemented by certain higher-end spirits brands. Its Corporate Operations and Other segment consists of costs of corporate development, corporate finance, corporate strategy, executive management, growth, human resources, internal audit, investor relations, IT, legal and public relations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Constellation Brands Reports Q4 Adjusted EPS of $1.90, Beating IBES Estimate of $1.72
Q4 Adjusted EPS: Constellation Brands reported an adjusted earnings per share (EPS) of $1.9 for Q4.
Comparison with Estimates: This EPS figure exceeded the analysts' estimate of $1.72.
See More
Constellation Brands Reports Q4 Sales of $1.92 Billion, Exceeding IBES Estimate of $1.88 Billion
- Sales Comparison: Constellation Brands reported Q4 sales of USD 1,920 million, surpassing estimates.
- Estimates Overview: The estimated sales by Ibes for the same period were USD 1,879 million.
See More
Trump Pauses Iran Strikes, Wall Street Rallies
- Market Rally: Wall Street closed higher on Wednesday, with the Nasdaq Composite up 2.8%, S&P 500 rising 2.5%, and Dow climbing 2.8%, following President Trump's agreement to pause planned strikes on Iran, indicating a positive market response to reduced geopolitical risks.
- ImmuCell Strong Performance: ImmuCell's stock surged 5.02% to $6.70 in after-hours trading after reporting first-quarter sales of $10.4 million, a 28.4% year-over-year increase, primarily driven by robust domestic sales, highlighting strong demand for its Tri-Shield product line.
- Costco Sales Growth: Despite reporting net sales of $28.41 billion for March, an 11.3% increase year-over-year, Costco's stock fell 0.52% to $1,024.92 in postmarket trading, reflecting market caution regarding future growth, even with e-commerce sales jumping 23.3%.
- Constellation Brands Soft Guidance: Constellation Brands faced pressure in after-hours trading after reporting fiscal fourth-quarter earnings of $1.90 per share, beating estimates, but issuing a fiscal 2027 earnings guidance below Wall Street expectations, indicating uncertainty in future market demand.
See More
Constellation Brands Reports Q4 Profit Rebound
- Profit Rebound: Constellation Brands reported a fourth-quarter net income of $201.8 million, or $1.16 per share, compared to a net loss of $375.3 million, or $2.09 per share last year, indicating a significant recovery in profitability and reflecting strong performance in market recovery.
- Sales Decline: Despite the profit rebound, net sales for the quarter were $1.920 billion, down from $2.164 billion last year, suggesting challenges in sales growth that may impact future market strategies.
- Future Outlook: The company anticipates fiscal 2027 reported earnings per share of $11.10 to $11.80 and comparable earnings per share of $11.20 to $11.90, alongside an operating cash flow target of $2.4 to $2.5 billion and a free cash flow target of $1.6 to $1.7 billion, demonstrating confidence in future financial health.
- Dividend Declaration: The board declared a quarterly cash dividend of $1.03 per share, payable on May 14, 2026, to shareholders of record as of April 29, 2026, reflecting the company's ongoing commitment to shareholder returns.
See More
Constellation Brands Withdraws Fiscal 2028 Outlook Amid Weaker Demand
- Outlook Withdrawal: Constellation Brands withdrew its previously issued fiscal 2028 outlook after reporting slightly weaker demand, indicating the impact of changing consumer behavior in a rapidly evolving macroenvironment.
- Q4 Performance Beats Expectations: Despite a 3% decline in overall sales for fiscal 2026, the company reported adjusted earnings per share of $1.90 for Q4, exceeding Wall Street's expectation of $1.72, showcasing growth momentum in its beer and wine segments.
- Significant Net Income Improvement: The company reported a net income of $224.7 million for Q4, a substantial recovery from a loss of $370.6 million a year prior, reflecting improved profitability amid economic uncertainty.
- Cautious Future Outlook: While the company expects adjusted EPS for fiscal 2027 to range between $11.20 and $11.90, below the market estimate of $12.36, this indicates a cautious stance on future economic conditions, particularly as consumer spending behavior becomes more deliberate.
See More
Constellation Brands Withdraws Fiscal 2028 Outlook Amid Subdued Demand
- Outlook Withdrawal: Constellation Brands withdrew its previously issued fiscal 2028 outlook on Wednesday, indicating subdued consumer demand amid a rapidly evolving macroenvironment, despite beating Wall Street expectations for the fourth quarter.
- Fourth Quarter Performance: The company reported adjusted earnings per share of $1.90, surpassing the expected $1.72, with revenue of $1.92 billion exceeding the $1.88 billion forecast, showcasing growth momentum in its beer and wine segments.
- Net Income Recovery: For the fourth quarter, net income reached $224.7 million, a significant recovery from a loss of $370.6 million a year prior, demonstrating the company's ability to achieve profitability despite economic uncertainties, thereby boosting market confidence.
- Cautious Future Outlook: Although Constellation Brands anticipates adjusted EPS for fiscal 2027 to be between $11.20 and $11.90, below the market estimate of $12.36, it emphasizes the importance of focus and discipline in navigating a dynamic operating environment.
See More
Constellation Brands Reports Q4 Adjusted EPS of $1.90, Beating IBES Estimate of $1.72
Q4 Adjusted EPS: Constellation Brands reported an adjusted earnings per share (EPS) of $1.9 for Q4.
Comparison with Estimates: This EPS figure exceeded the analysts' estimate of $1.72.
See More
Constellation Brands Reports Q4 Sales of $1.92 Billion, Exceeding IBES Estimate of $1.88 Billion
- Sales Comparison: Constellation Brands reported Q4 sales of USD 1,920 million, surpassing estimates.
- Estimates Overview: The estimated sales by Ibes for the same period were USD 1,879 million.
See More
Trump Pauses Iran Strikes, Wall Street Rallies
- Market Rally: Wall Street closed higher on Wednesday, with the Nasdaq Composite up 2.8%, S&P 500 rising 2.5%, and Dow climbing 2.8%, following President Trump's agreement to pause planned strikes on Iran, indicating a positive market response to reduced geopolitical risks.
- ImmuCell Strong Performance: ImmuCell's stock surged 5.02% to $6.70 in after-hours trading after reporting first-quarter sales of $10.4 million, a 28.4% year-over-year increase, primarily driven by robust domestic sales, highlighting strong demand for its Tri-Shield product line.
- Costco Sales Growth: Despite reporting net sales of $28.41 billion for March, an 11.3% increase year-over-year, Costco's stock fell 0.52% to $1,024.92 in postmarket trading, reflecting market caution regarding future growth, even with e-commerce sales jumping 23.3%.
- Constellation Brands Soft Guidance: Constellation Brands faced pressure in after-hours trading after reporting fiscal fourth-quarter earnings of $1.90 per share, beating estimates, but issuing a fiscal 2027 earnings guidance below Wall Street expectations, indicating uncertainty in future market demand.
See More
Constellation Brands Reports Q4 Profit Rebound
- Profit Rebound: Constellation Brands reported a fourth-quarter net income of $201.8 million, or $1.16 per share, compared to a net loss of $375.3 million, or $2.09 per share last year, indicating a significant recovery in profitability and reflecting strong performance in market recovery.
- Sales Decline: Despite the profit rebound, net sales for the quarter were $1.920 billion, down from $2.164 billion last year, suggesting challenges in sales growth that may impact future market strategies.
- Future Outlook: The company anticipates fiscal 2027 reported earnings per share of $11.10 to $11.80 and comparable earnings per share of $11.20 to $11.90, alongside an operating cash flow target of $2.4 to $2.5 billion and a free cash flow target of $1.6 to $1.7 billion, demonstrating confidence in future financial health.
- Dividend Declaration: The board declared a quarterly cash dividend of $1.03 per share, payable on May 14, 2026, to shareholders of record as of April 29, 2026, reflecting the company's ongoing commitment to shareholder returns.
See More
Constellation Brands Withdraws Fiscal 2028 Outlook Amid Weaker Demand
- Outlook Withdrawal: Constellation Brands withdrew its previously issued fiscal 2028 outlook after reporting slightly weaker demand, indicating the impact of changing consumer behavior in a rapidly evolving macroenvironment.
- Q4 Performance Beats Expectations: Despite a 3% decline in overall sales for fiscal 2026, the company reported adjusted earnings per share of $1.90 for Q4, exceeding Wall Street's expectation of $1.72, showcasing growth momentum in its beer and wine segments.
- Significant Net Income Improvement: The company reported a net income of $224.7 million for Q4, a substantial recovery from a loss of $370.6 million a year prior, reflecting improved profitability amid economic uncertainty.
- Cautious Future Outlook: While the company expects adjusted EPS for fiscal 2027 to range between $11.20 and $11.90, below the market estimate of $12.36, this indicates a cautious stance on future economic conditions, particularly as consumer spending behavior becomes more deliberate.
See More
Constellation Brands Withdraws Fiscal 2028 Outlook Amid Subdued Demand
- Outlook Withdrawal: Constellation Brands withdrew its previously issued fiscal 2028 outlook on Wednesday, indicating subdued consumer demand amid a rapidly evolving macroenvironment, despite beating Wall Street expectations for the fourth quarter.
- Fourth Quarter Performance: The company reported adjusted earnings per share of $1.90, surpassing the expected $1.72, with revenue of $1.92 billion exceeding the $1.88 billion forecast, showcasing growth momentum in its beer and wine segments.
- Net Income Recovery: For the fourth quarter, net income reached $224.7 million, a significant recovery from a loss of $370.6 million a year prior, demonstrating the company's ability to achieve profitability despite economic uncertainties, thereby boosting market confidence.
- Cautious Future Outlook: Although Constellation Brands anticipates adjusted EPS for fiscal 2027 to be between $11.20 and $11.90, below the market estimate of $12.36, it emphasizes the importance of focus and discipline in navigating a dynamic operating environment.
See More
